Literature DB >> 10541527

Numbers needed to treat derived from meta-analysis. Are an absurdity.

B G Charlton.   

Abstract

Mesh：

Year:  1999        PMID： 10541527      PMCID： PMC1116975     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Calculating the number needed to treat for trials where the outcome is time to an event.

Authors:  D G Altman; P K Andersen
Journal:  BMJ       Date:  1999-12-04

Review 2.  Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.

Authors:  L Smeeth; A Haines; S Ebrahim
Journal:  BMJ       Date:  1999-06-05

3.  Using numerical results from systematic reviews in clinical practice.

Authors:  H J McQuay; R A Moore
Journal:  Ann Intern Med       Date:  1997-05-01       Impact factor: 25.391

4.  Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects.

Authors:  A R Moore; David Gavaghan; R M Tramèr; L S Collins; J H McQuay
Journal:  Pain       Date:  1998-12       Impact factor: 6.961

5.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

6.  The future of clinical research: from megatrials towards methodological rigour and representative sampling.

Authors:  B G Charlton
Journal:  J Eval Clin Pract       Date:  1996-08       Impact factor: 2.431

7.  Oral aspirin in postoperative pain: a quantitative systematic review.

Authors:  Jayne E Edwards; Anna D Oldman; Lesley A Smith; Dawn Carroll; Philip J Wiffen; Henry J McQuay; Andrew R Moore
Journal:  Pain       Date:  1999-06       Impact factor: 6.961

8.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

Review 10.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.